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ABSTRACT 
OBJECTIVE: 
 “The efficacy of Botulinum Toxin-A versus Methyl Prednisolone Acetate 
injection in reducing  pain and improving functional outcome in plantar fasciitis’’ 
 
STUDY DESIGN: 
 A Randomized Controlled Study. 
 
SAMPLE SIZE: 
 100 participants with plantar fasciitis divided into two groups by  simplified 
randomized controlled method. 
 
METHODS: 
 Participants in group 1 received 50 units of Botulinum Toxin-A which is mixed 
with given normal saline and group 2 received 40mg Methyl Prednisolone Acetate 
around plantar fascia close to calcaneal tuberosity.Participants are followed up at 1 
month,2 month,4 month and 6month after intervention.Plantar fascia thickness before 
and after intervention done at 6 months by using Ultrasonagram . 
 
OUTCOME MEASURES: 
 Visual analogue pain scale(VAS) and Foot ankle ability measure score(FAAM) 
are done at follow up months. 
 
  
RESULTS: 
 This study shows statistically significant changes in both groups in first 4 
months but the Botulinum Toxin-A group shows better pain relief and functional 
improvement ( p value <0.0001) and it is maintained at 6 months in comparison to 
Methyl prednisolone acetate group (p value <0.001).No side effects are noted in 
Botulinum Toxin-A group. 
 
CONCLUSION: 
 Botulinum Toxin-A injection is found to be cost effective in chronic plantar 
fasciitis and it yields significant pain relief and functional improvement and it is 
maintained at 6 months when compared with steroid where there is significant decline 
in functional improvement after 4 months. 
 
KEY WORDS: 
             Plantar fasciitis,Botulinum Toxin-A,Ultrasonagram,Visual analogue pain 
scale,Foot ankle ability measure. 
 
  
 
